Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-25-000347·BIOLIFE SOLUTIONS INC
Schedule 13G ownership disclosure
BioLife Solutions Inc
COMMON STOCK · CUSIP: 09062W204
Event date: 2025-06-30
- Filing-level shares
- 4,246,706
- Percent of class
- 8.9%
- T. Rowe Price Investment Management, Inc.
Shares: 4,246,706 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000347
- Form type
- SCHEDULE 13G
- Filer
- BIOLIFE SOLUTIONS INC
- CIK
- CIK 834365
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership